Asunercept not checked
Apogenix AG · CAN008 · APG101
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- A decoy protein that soaks up a signal molecule before it can reach the body's cells.-cept: receptor molecules, native or modified WHO name stem
- How it’s given
- “Asunercept (APG101) will be administered once per week as an i.v. infusion”In the company’s words, NCT05639192 on ClinicalTrials.gov
- Tested for
- COVID-19, COVID-19 Induced Pneumonia, Covid19, Newly-diagnosed Glioblastoma
- Main trialPhase 3
- “This clincial trial is a prospective, multicenter, randomized, double-blind, placebo-controlled Phase III trial in hospitalized patients with moderate to severe COVID-19 corresponding to score 5 or 6 on the WHO 10-point clinical progression scale (Grade 0-10). The investigational drug (APG101; International Nonproprietary Name: asunercept) will be given at a dose of 100 mg intravenously (i.v.) once weekly for a period of 4 weeks (1 dose each on d1, d8, d15, and d22) in addition to the treatment recommended by international, national, or local treatment guidelines (SoC) and will be compared…”In the company’s words, NCT05639192 on ClinicalTrials.gov
- Other names
- CAN008 · APG101
Other drugs for COVID-19
- MaravirocHealthBio, Inc. · Phase 2/3
- REGENECYTEStemCyte, Inc. · Phase 3
- VYD2311Invivyd, Inc. · Phase 3
- SecutrelvirShionogi · Phase 3
- IbuzatrelvirPfizer · Phase 3
- TozorakimabAstraZeneca · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Terminated | 18 Aug 2023 | Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease | |
| Phase 2Completed | 29 Oct 2021 | Asunercept in Patients With Severe COVID-19 | |
| Phase 2Unknown | 31 Jan 2024 | Phase 2 Study of CAN008 in Subjects With GBM |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026